Evaluation of dependent variable, time effect, covariates, and covariation structure in concentration-QTc modeling: A...

Area of Science:

• Pharmacology and Toxicology
• Clinical Trial Methodology
• Biostatistics

Background:

• The International Council for Harmonisation (ICH) E14 R3 guideline permits concentration-QTc (C-QTc) modeling for assessing drug-induced QTc prolongation risk.
• Current C-QTc modeling approaches may not fully capture temporal dynamics of drug effects on the QT interval.
• Optimizing C-QTc modeling is crucial for accurate drug safety evaluations.

Purpose of the Study:

• To evaluate the performance of various C-QTc modeling strategies under different conditions.
• To assess the impact of including time effects in C-QTc models.
• To identify optimal C-QTc modeling approaches for reliable QTc prolongation risk assessment.

Main Methods:

• A simulation study was conducted to compare different C-QTc models.
• Models varied in dependent variables (e.g., ΔQTc), covariates, and covariance structures.
• Performance was evaluated based on the control of false negative and false positive rates.

Main Results:

• C-QTc models using ΔQTc as the dependent variable without time effects demonstrated an inflated false negative rate.
• The choice of dependent variable, covariates, and covariance structure significantly influenced the control of false positive and false negative rates.
• Specific C-QTc modeling strategies were identified as superior for managing these error rates.

Conclusions:

• Appropriate C-QTc modeling is essential for accurate assessment of QTc prolongation risk.
• Incorporating time effects into C-QTc models is recommended to avoid inflated false negative rates.
• The study provides recommendations for C-QTc modeling strategies that effectively control both false negative and false positive rates in drug development.